116 related articles for article (PubMed ID: 9814730)
1. Differential effects of inhaled budesonide on serum osteocalcin in children and adolescents with asthma.
Wolthers OD; Heuck C
Pediatr Allergy Immunol; 1998 Aug; 9(3):150-5. PubMed ID: 9814730
[TBL] [Abstract][Full Text] [Related]
2. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover?
Schou AJ; Heuck C; Wolthers OD
Pediatr Pulmonol; 2003 Nov; 36(5):399-404. PubMed ID: 14520722
[TBL] [Abstract][Full Text] [Related]
3. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.
Birkebaek NH; Esberg G; Andersen K; Wolthers O; Hassager C
Arch Dis Child; 1995 Dec; 73(6):524-7. PubMed ID: 8546510
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration.
Heuck C; Wolthers OD; Kollerup G; Hansen M; Teisner B
J Pediatr; 1998 Nov; 133(5):608-12. PubMed ID: 9821415
[TBL] [Abstract][Full Text] [Related]
5. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids.
Crowley S; Trivedi P; Risteli L; Risteli J; Hindmarsh PC; Brook CG
J Pediatr; 1998 Mar; 132(3 Pt 1):409-13. PubMed ID: 9544892
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide.
Heuck C; Heickendorff L; Wolthers OD
Arch Dis Child; 2000 Oct; 83(4):334-9. PubMed ID: 10999872
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled study of three osteocalcin assays for assessment of prednisolone-induced suppression of bone turnover.
Heuck C; Wolthers OD
J Endocrinol; 1998 Oct; 159(1):127-31. PubMed ID: 9795350
[TBL] [Abstract][Full Text] [Related]
8. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[TBL] [Abstract][Full Text] [Related]
9. Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide.
Wolthers OD; Riis BJ; Pedersen S
Pediatr Pulmonol; 1993 Dec; 16(6):341-6. PubMed ID: 8134155
[TBL] [Abstract][Full Text] [Related]
10. Serum leptin in children with asthma treated with inhaled budesonide.
Heuck C; Wolthers OD
Respir Med; 1999 Apr; 93(4):268-71. PubMed ID: 10464891
[TBL] [Abstract][Full Text] [Related]
11. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids.
Hanania NA; Chapman KR; Sturtridge WC; Szalai JP; Kesten S
J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):571-9. PubMed ID: 7499672
[TBL] [Abstract][Full Text] [Related]
12. Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma.
Jónasson G; Carlsen KH; Jonasson C; Mowinckel P
Allergy; 2000 Aug; 55(8):740-8. PubMed ID: 10955700
[TBL] [Abstract][Full Text] [Related]
13. Short-term growth and collagen turnover in asthmatic adolescents treated with the inhaled glucocorticoid budesonide.
Heuck C; Wolthers OD; Hansen M; Kollerup G
Steroids; 1997 Oct; 62(10):659-64. PubMed ID: 9381513
[TBL] [Abstract][Full Text] [Related]
14. Inhaled budesonide for adults with mild-to-moderate asthma: a randomized placebo-controlled, double-blind clinical trial.
Fernandes AL; Faresin SM; Amorim MM; Fritscher CC; Pereira CA; Jardim JR
Sao Paulo Med J; 2001 Sep; 119(5):169-74. PubMed ID: 11723527
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW; Wisniewski A; Honour J; Tattersfield AE
Thorax; 2001 Mar; 56(3):186-91. PubMed ID: 11182010
[TBL] [Abstract][Full Text] [Related]
16. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma.
Allen HD; Thong IG; Clifton-Bligh P; Holmes S; Nery L; Wilson KB
Pediatr Pulmonol; 2000 Mar; 29(3):188-93. PubMed ID: 10686039
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
Mellon M
J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
[TBL] [Abstract][Full Text] [Related]
20. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
